The results in Figure 6A and 6B, show that docetaxel, gefitinib and NS-398 each separately downregulated NF-ΚB, MMP-9 and VEGF mRNA expression in both PCa cell lines. The gene discussed is MMP9; the disease is posterior cortical atrophy.